PoreWise

One finding · Human trial · 2026

Study title

Shake-Induced Temporary Ion-Pairing Between Lecithin and Glycolic Acid for Enhanced Exfoliation in a Novel Biphasic Serum: Comparative Ex Vivo and in Vivo Randomised Studies

Kind of evidence
Human trial 2026 · 37 people · participants in a split-face study · PMID 41987370
Measured outcome
Skin effect
Year
2026
Who was studied
37 participants in a split-face study
Sample size
37
Measured outcome
In a 2-week double-blind split-face study of 37 participants, a biphasic serum with 10% glycolic acid delivered 45.52% greater exfoliation (p<0.001) and improved skin brightness, texture and hydration versus the comparison side.
Certainty
Moderate
Who was measured
Healthy participants using a 10% glycolic acid biphasic serum on one side of the face for 2 weeks.
Study limits
Short duration (2 weeks) and a single product formulation; the study measured exfoliation and cosmetic parameters.

Where it comes from

PMID 41987370

Ingredients it was measured on

Skin concerns studied

Other findings on the same ingredient or concern

  1. Skin effect
    The effect of physically applied alpha hydroxyl acids on the skin pore and comedone

    In 23 women, a single application of a 4% alpha-hydroxy acid solution combined with negative-pressure physical action significantly reduced whitehead and blackhead counts at 1, 2 and 4 weeks, and reduced pore area and number at week 1, compared with AHA peeling alone.

    Human trial · 2015 · 23 people · healthy women (mean age 30) · Healthy women receiving a single in-clinic application in a randomised split-face design, assessed at 1, 2 and 4 weeks. · The intervention was a single in-clinic chemical peeling plus negative-pressure physical action.

    PMID 26032934

  2. Skin effect
    Comparative study of buffered 50% glycolic acid (pH 3.0) + 0.5% salicylic acid solution vs Jessner's solution in patients with acne vulgaris

    In a prospective, randomized, evaluator-blind, split-face trial of 20 patients with acne vulgaris, two 50% glycolic acid + 0.5% salicylic acid peels significantly reduced total lesion count (P<0.001) and produced fewer side effects than Jessner's solution.

    Human trial · 2018 · 20 people · patients with acne vulgaris · Patients with acne vulgaris receiving two 50% glycolic acid + 0.5% salicylic acid peels 2 weeks apart (one side vs Jessner's solution on the other). · Small sample (20) and a combination peel (glycolic + salicylic acid); this is a procedural peel.

    PMID 29164826

  3. Skin effect
    Assessing the Value of Botanical Anti-Inflammatory Agents in an OTC Acne Treatment Regimen

    In a 12-week randomized trial of 80 subjects aged 12 and over with mild-to-moderate acne, a botanical anti-inflammatory OTC skincare regimen produced significantly lower closed-comedone counts than a benzoyl peroxide comparator at week 4 (P<0.001) and week 12 (P=0.006), with fewer inflammatory lesions at week 4 (P=0.016).

    Human trial · 2015 · 80 people · subjects aged 12+ with mild-to-moderate acne · Closed-comedone and inflammatory lesion counts over 12 weeks. · The comparator is an active benzoyl peroxide regimen.

    PMID 26659934

  4. Skin effect
    Evaluation of anti-wrinkle effects of a novel cosmetic containing niacinamide

    In a randomized, placebo-controlled split-face study of 30 healthy Japanese women, a cosmetic containing 4% niacinamide reduced the skin-surface average roughness (Ra) value significantly more than the niacinamide-free control site after 8 weeks (P<0.05).

    Human trial · 2008 · 30 people · healthy Japanese women with wrinkles in the eye areas · Skin-surface roughness measured by replica profilometry (Ra). · Measured at the eye area on a photoaged/wrinkle cohort; the endpoint is surface roughness.

    PMID 19017042

  5. Skin effect
    Efficacy and safety of a novel anhydrous 0.1% retinal and 10% azelaic acid concentrate for blemish-prone skin: an eight-week randomized prospective split-face, vehicle-controlled study

    In an 8-week randomized, vehicle-controlled split-face study of 23 people with blemish-prone skin, an anhydrous 0.1% retinal / 10% azelaic acid concentrate improved the pore parameter by 22.3% versus vehicle (p=0.015) and skin texture by 5.6% versus vehicle (p=0.0016), and reduced surface irregularities by 12.7% versus vehicle (p=0.0053).

    Human trial · 2026 · 23 people · participants aged 16-49 (mean 28), Fitzpatrick I-IV, blemish-prone skin · Pore appearance, skin texture and surface irregularities on the face over 8 weeks. · The pore improvement versus baseline was borderline (15.9%, p=0.051); the small sample completed 23 participants; the product is a six-ingredient concentrate; 10% azelaic acid is regulated as an OTC drug in some markets.

    PMID 42572367